Menu
Du musst dich anmelden oder registrieren, bevor du fortfahren kannst.
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
Compagnie Financière Richemont SA ADR

Start price
Target price
Perf. (%)
€6.50
06.11.20
€6.00
2.97%
10.11.20

Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
buy
NIO Inc. ADR

Start price
Target price
Perf. (%)
€37.30
06.11.20
€40.00
7.51%
12.11.20

Innovative
EBIT growth >5% per year expected
Top 10 in its market
Known brand
buy
Farfetch Ltd

Start price
Target price
Perf. (%)
€35.80
06.11.20
€40.00
5.03%
11.11.20

Top 10 in its market
Known brand
Probably not worthwhile Investment
Low dividend yield expected
buy
Ose Pharma International S.A.

Start price
Target price
Perf. (%)
€9.36
06.11.20
€14.00
06.11.21
23.50%
21.09.21

Could be worthwhile Investment >10% per year
buy
Amazon.com Inc.

Start price
Target price
Perf. (%)
€139.78
06.11.20
€160.00
06.11.21
12.75%
08.07.21

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
High valuation
buy
T-Mobile US Inc.

Start price
Target price
Perf. (%)
€104.52
06.11.20
€100.00
2.26%
12.11.20

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Valuable balance sheet
ROE higher than 10% per year
Sfc Energy AG

Start price
Target price
Perf. (%)
€14.64
05.11.20
-
05.11.21
14.21%
18.01.21

Outdated or very high risk business model
High risks for its business
Risky Investment
buy
NIO Inc. ADR

Start price
Target price
Perf. (%)
€34.70
05.11.20
€40.00
7.49%
06.11.20

Innovative
EBIT growth >5% per year expected
Top 10 in its market
Known brand
buy
Cliq Digital AG

Start price
Target price
Perf. (%)
€18.30
05.11.20
€20.00
3.83%
17.11.20

Undervalued
ROE higher than 15% per year
Revenue growth > 30% per year expected
Small Risks for its business
Oncternal Therapeutics Inc.

Start price
Target price
Perf. (%)
€2.50
05.11.20
-
05.11.21
47.44%
06.11.21

buy
Bitcoin Group SE

Start price
Target price
Perf. (%)
€29.25
05.11.20
€50.00
05.11.21
81.88%
06.11.21

Revenue growth >5% per year expected
positive Cash Flow expected
Standard Investments for future growth
Risky balance sheet
buy
BioNTech SE ADR

Start price
Target price
Perf. (%)
€77.54
05.11.20
-
05.11.21
20.98%
27.11.20

Rising EBIT margin expected
Good rating
High Investments for future growth
Valuable balance sheet
buy
Invesco Ltd.

Start price
Target price
Perf. (%)
€12.21
05.11.20
-
05.11.21
49.23%
03.02.21

Future proof or reliable business model
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Below average Management
buy
Ferrari NV

Start price
Target price
Perf. (%)
€173.50
05.11.20
€185.00
-0.23%
06.11.20

Revenue growth > 30% per year expected
Undervalued
Very Future proof/growth oriented business model
Well known brand
Cassava Sciences Inc.

Start price
Target price
Perf. (%)
€9.05
05.11.20
-
05.11.21
728.91%
06.11.21

Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
buy
Meta Platforms Inc.

Start price
Target price
Perf. (%)
€247.50
05.11.20
€255.00
-8.42%
11.12.20

Top 10 in its market
Revenue growth >5% per year expected
Good rating
Some uniques
buy
Sio Gene Therapies Inc.

Start price
Target price
Perf. (%)
€1.87
05.11.20
€2.00
05.11.21
-7.97%
06.11.21

Future proof or reliable business model
buy
Applied DNA Sciences Inc.

Start price
Target price
Perf. (%)
€5.90
05.11.20
€20.00
05.11.21
-17.29%
06.11.21

Market Leader or Top 3
Could be very worthwhile Investment >20% year
Very Future proof/growth oriented business model
Aphria Inc.

Start price
Target price
Perf. (%)
€4.70
05.11.20
-
05.11.21
170.32%
06.11.21

Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
buy
Delivery Hero SE

Start price
Target price
Perf. (%)
€112.60
05.11.20
€120.00
2.98%
16.12.20

Could be worthwhile Investment >10% per year
Market Leader or Top 3
Well known brand
Very Future proof/growth oriented business model
EOG Resources Inc.

Start price
Target price
Perf. (%)
€30.40
05.11.20
-
05.11.21
57.24%
09.01.21

High dividend yield expected
Sustainability is little important
Higher risks for its business
Significant cyclical dependencies
buy
Cadence Design Systems

Start price
Target price
Perf. (%)
€103.62
05.11.20
€150.00
05.11.21
48.54%
06.11.21

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
ROE higher than 15% per year
buy
ProSiebenSat.1 Media SE

Start price
Target price
Perf. (%)
€9.99
04.11.20
-
27.08%
25.11.20

Risky Investment
buy
Jumia Technologies AG

Start price
Target price
Perf. (%)
€15.20
04.11.20
€49.00
04.11.21
59.87%
19.04.21

Good rating
Standard Investments for future growth
High valuation
Very low/no dividend yield expected
buy
Washington Prime Group Inc.

Start price
Target price
Perf. (%)
€4.76
04.11.20
€6.30
04.11.21
-11.41%
06.11.20

Differentiated customer and product portfolio
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Fair valuation